+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Atenolol Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • August 2024
  • Region: Global
  • The Business Research Company
  • ID: 5991131
Atenolol belongs to the beta-blocker class of medications, primarily used to treat cardiovascular conditions. It's commonly prescribed for managing hypertension, angina, and preventing heart attacks. Atenolol is administered orally in tablet form, known for its efficacy in regulating heart function and lowering blood pressure.

The main types of atenolol are categorized based on purity, typically 98% and 99%. Purity percentage indicates the substance's freedom from impurities. Atenolol is available in various forms such as tablets and IV solutions, distributed through channels such as hospital pharmacies, drug stores, and online platforms. It is utilized for treating conditions such as hypertension, angina, arrhythmia, among others.

The atenolol market research report is one of a series of new reports that provides atenolol market statistics, including atenolol industry global market size, regional shares, competitors with an atenolol market share, detailed atenolol market segments, market trends, and opportunities, and any further data you may need to thrive in the atenolol industry. This atenolol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The atenolol market size has grown strongly in recent years. It will grow from $11.05 billion in 2023 to $12.01 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth observed in the historic period can be attributed to several factors, including increased demand and consumption of antihypertensive drugs, a larger patient pool with conditions such as arrhythmia and angina, a rise in the prevalence of glaucoma and arrhythmia, and an increase in the popularity of online pharmacies.

The atenolol market size is expected to see strong growth in the next few years. It will grow to $15.85 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The expected growth in the forecast period can be attributed to several factors, including the increasing demand for atenolol, a growing prevalence of hypertension, heightened awareness of the complexities related to hypertension, a significant rise in the aging population, and poor lifestyle and dietary habits leading to cardiovascular issues. Major trends anticipated during this period include a demand for beta blockers, specifically beta-1 selective blockers, recent regulatory approvals for new formulations, the development of extended-release formulations, and a rising demand for combination therapies in treating cardiovascular conditions.

The atenolol market is poised for growth driven by the increasing prevalence of cardiovascular diseases (CVDs). CVDs encompass a range of disorders affecting the heart and blood vessels and are on the rise due to factors such as population growth, aging demographics, various risk factors, and gaps in implementing proven prevention and treatment strategies. Atenolol plays a pivotal role in managing CVDs by reducing heart rate, lowering blood pressure, alleviating angina symptoms, preventing heart attacks, and managing arrhythmias. Its ability to stabilize heart function, control blood pressure, and prevent complications contributes significantly to long-term cardiovascular health. For example, the Centers for Disease Control and Prevention reported that the prevalence of coronary heart disease among adults aged 18 and over slightly increased from 4.6% in 2020 to 4.9% in 2021, highlighting the impact of growing CVD prevalence on the atenolol market.

The rising prevalence of hypertension, also known as high blood pressure, is expected to drive the growth of the atenolol market. Hypertension is characterized by consistently elevated blood pressure against arterial walls and is influenced by lifestyle choices, dietary habits, stress levels, and demographic shifts. Atenolol helps manage hypertension by reducing heart rate, diminishing the force of heart contractions, and inhibiting the renin-angiotensin-aldosterone system, collectively lowering blood pressure and mitigating hypertension-related complications. According to the World Health Organization, an estimated 1.28 billion adults aged 30-79 worldwide have hypertension, underscoring the role of hypertension prevalence in propelling the atenolol market.

In April 2023, Marksans Pharma completed the acquisition of Teva Pharmaceutical Industries, aiming to expand its manufacturing capacity in India and diversify its product portfolio. Teva Pharmaceutical Industries, based in Israel, is a key manufacturer of atenolol.

Major companies operating in the atenolol market are F. Hoffmann-La Roche Ltd., AstraZeneca Plc, Abbott Laboratories Inc., Shanghai Pharmaceuticals Holding Co. Ltd., LGM Pharma, Torrent Pharmaceuticals GmbH, Cipla Inc., Intas Pharmaceuticals Limited, Lupin Limited, Macleods Pharmaceuticals Ltd., Ipca Laboratories Limited, Aristo Pharmaceuticals Pvt. Ltd, Medley Pharmaceuticals Ltd., Micro Labs Ltd., Unichem Laboratories Limited, Harman Finochem Ltd., Axplora, Erregierre SpA, Darou Pakhsh Pharma Chem Co., Zydus Pharmaceuticals (USA) Inc., Anant Pharmaceuticals Pvt. Ltd., Enomark LLC, Hairui Chemical, Octavius Pharma Pvt. Ltd., Hoventa Pharma.

North America was the largest region in the atenolol market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atenolol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the atenolol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The atenolol market consists of sales of atenolol tablets, atenolol injections, fixed-dose combinations, and distribution channels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Atenolol Market Characteristics3. Atenolol Market Trends And Strategies
4. Atenolol Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Atenolol Market Size and Growth
5.1. Global Atenolol Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Atenolol Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Atenolol Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Atenolol Market Segmentation
6.1. Global Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 98% Purity
  • 99% Purity
6.2. Global Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Tablets
  • IV Solution
  • Other Forms
6.3. Global Atenolol Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Other Distribution Channels
6.4. Global Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hypertension
  • Angina
  • Arrhythmia
  • Other Applications
7. Atenolol Market Regional And Country Analysis
7.1. Global Atenolol Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Atenolol Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Atenolol Market
8.1. Asia-Pacific Atenolol Market Overview
(Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies)
8.2. Asia-Pacific Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Atenolol Market
9.1. China Atenolol Market Overview
9.2. China Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Atenolol Market
10.1. India Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Atenolol Market
11.1. Japan Atenolol Market Overview
11.2. Japan Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Atenolol Market
12.1. Australia Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Atenolol Market
13.1. Indonesia Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Atenolol Market
14.1. South Korea Atenolol Market Overview
14.2. South Korea Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Atenolol Market
15.1. Western Europe Atenolol Market Overview
15.2. Western Europe Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Atenolol Market
16.1. UK Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Atenolol Market
17.1. Germany Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Atenolol Market
18.1. France Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Atenolol Market
19.1. Italy Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Atenolol Market
20.1. Spain Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Atenolol Market
21.1. Eastern Europe Atenolol Market Overview
21.2. Eastern Europe Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Atenolol Market
22.1. Russia Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Atenolol Market
23.1. North America Atenolol Market Overview
23.2. North America Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Atenolol Market
24.1. USA Atenolol Market Overview
24.2. USA Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Atenolol Market
25.1. Canada Atenolol Market Overview
25.2. Canada Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Atenolol Market
26.1. South America Atenolol Market Overview
26.2. South America Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Atenolol Market
27.1. Brazil Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Atenolol Market
28.1. Middle East Atenolol Market Overview
28.2. Middle East Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Atenolol Market
29.1. Africa Atenolol Market Overview
29.2. Africa Atenolol Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Atenolol Market, Segmentation By Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Atenolol Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Atenolol Market Competitive Landscape And Company Profiles
30.1. Atenolol Market Competitive Landscape
30.2. Atenolol Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. AstraZeneca Plc
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Abbott Laboratories Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Shanghai Pharmaceuticals Holding Co. Ltd.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. LGM Pharma
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Atenolol Market Other Major And Innovative Companies
31.1. Torrent Pharmaceuticals GmbH
31.2. Cipla Inc.
31.3. Intas Pharmaceuticals Limited
31.4. Lupin Limited
31.5. Macleods Pharmaceuticals Ltd.
31.6. Ipca Laboratories Limited
31.7. Aristo Pharmaceuticals Pvt. Ltd
31.8. Medley Pharmaceuticals Ltd.
31.9. Micro Labs Ltd.
31.10. Unichem Laboratories Limited
31.11. Harman Finochem Ltd.
31.12. Axplora
31.13. Erregierre SpA
31.14. Darou Pakhsh Pharma Chem Co.
31.15. Zydus Pharmaceuticals (USA) Inc.
32. Global Atenolol Market Competitive Benchmarking33. Global Atenolol Market Competitive Dashboard34. Key Mergers And Acquisitions In The Atenolol Market
35. Atenolol Market Future Outlook and Potential Analysis
35.1 Atenolol Market In 2028 - Countries Offering Most New Opportunities
35.2 Atenolol Market In 2028 - Segments Offering Most New Opportunities
35.3 Atenolol Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright And Disclaimer

Executive Summary

Atenolol Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on atenolol market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for atenolol ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The atenolol market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: 98% Purity; 99% Purity
2) By Form: Tablets; IV Solution; Other Forms
3) By Distribution Channel: Hospital Pharmacies; Drug Stores; Online Pharmacies; Other Distribution Channels
4) By Application: Hypertension; Angina; Arrhythmia; Other Applications

Key Companies Mentioned: F. Hoffmann-La Roche Ltd.; AstraZeneca Plc; Abbott Laboratories Inc.; Shanghai Pharmaceuticals Holding Co. Ltd.; LGM Pharma

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • AstraZeneca Plc
  • Abbott Laboratories Inc.
  • Shanghai Pharmaceuticals Holding Co. Ltd.
  • LGM Pharma
  • Torrent Pharmaceuticals GmbH
  • Cipla Inc.
  • Intas Pharmaceuticals Limited
  • Lupin Limited
  • Macleods Pharmaceuticals Ltd.
  • Ipca Laboratories Limited
  • Aristo Pharmaceuticals Pvt. Ltd
  • Medley Pharmaceuticals Ltd.
  • Micro Labs Ltd.
  • Unichem Laboratories Limited
  • Harman Finochem Ltd.
  • Axplora
  • Erregierre SpA
  • Darou Pakhsh Pharma Chem Co.
  • Zydus Pharmaceuticals (USA) Inc.
  • Anant Pharmaceuticals Pvt. Ltd.
  • Enomark LLC
  • Hairui Chemical
  • Octavius Pharma Pvt. Ltd.
  • Hoventa Pharma

Methodology

Loading
LOADING...